Redcliffe Labs, a leading pan-India omnichannel diagnostic company in India, has announced the launch of the BD MAX MDR TB test, which can detect multidrug-resistant tuberculosis (MDR-TB) in a single test, enabling clinicians to quickly test for TB and multidrug resistance as a first-line test.
To enable clinicians to rapidly test for TB and multidrug resistance as a first-line test, Redcliffe Labs becomes the first diagnostics company in India to launch the BD MAX MDR TB test which is performed on BD MAX™ molecular diagnostic system. Presently there are two different tests
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
